Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs crawled time : 15:00 save search
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.08%
H: 0.15%
C: -0.44%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.06%
H: 0.96%
C: 0.26%
CAH | $106.0 -0.49% -0.94% 1.5M
|
Distribution Services
|
| O: 0.02%
H: 0.73%
C: -0.02%
LNTH | News | $62.34 1.4% 1.38% 1.3M
|
Health Technology
|
| O: 0.1%
H: 1.98%
C: -0.08%
reach cancer treatment market
Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -20.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PPCB | $0.0014 -41.86% 4.4M
|
Manufacturing
|
| O: 0.0%
H: 2.61%
C: -4.35%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
active market
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Published: 2023-11-24 (Crawled : 15:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.89%
H: 0.39%
C: 0.19%
sandimmune solution novartis 100
T-cell Therapy Market Size to Grow USD US$ 76.6 billion from 2023-2033 | Says Transparency Market Research Inc.
Published: 2023-11-06 (Crawled : 15:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.54%
H: 0.73%
C: 0.2%
t-cell research therapy market
Global Sustained Release Excipients Markets, 2017-2022, 2022-2027F, 2032F: Escalating Demand for Advanced Drug Formulations, Fueled by Higher Prevalence of Chronic and Acute Diseases
Published: 2023-09-29 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: -1.26%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: -1.46%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.18%
H: 0.06%
C: -1.62%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.52%
H: 0.37%
C: -0.77%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 2.02%
H: 0.0%
C: -1.54%
drug global
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $116.59 -1.1% -1.12% 500K
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $22.62 0.4% 0.4% 1.3M
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Global Plant Based API Market Analysis Report 2023-2028: Many Pharmaceutical Companies are Now Developing Plant-based APIs to Meet Demand
Published: 2023-08-28 (Crawled : 15:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.06%
H: 0.06%
C: -0.51%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: 0.0%
companies report global market
Viral Vector Manufacturing Market worth $12.8 billion | MarketsandMarkets
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: -2.56%
LZAGY | $57.3 0.02% 33K
|
Professional, Scientific, and T...
|
| O: -0.59%
H: 0.02%
C: 0.02%
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 0.35%
H: 0.91%
C: 0.71%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: 0.0%
H: 1.29%
C: 1.14%
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.08%
H: 5.1%
C: 3.86%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.37%
H: 0.29%
C: -5.41%
market
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -0.68%
H: 3.23%
C: 1.55%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.62%
H: 4.57%
C: 2.04%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: 0.0%
H: 11.57%
C: 6.4%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.99%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -0.86%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -0.75%
H: 7.14%
C: 6.12%
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: 0.0%
H: 4.4%
C: 3.29%
drug set therapy growth market
DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published: 2023-05-23 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: -0.62%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -1.22%
GKOS M | $95.13 -1.82% 0.0% 380K
|
Health Technology
|
| O: -0.71%
H: 2.06%
C: -1.05%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -2.27%
H: 4.24%
C: -2.21%
ALC | $78.47 -0.67% -0.01% 760K
|
Health Technology
|
| O: -0.51%
H: 0.02%
C: -3.25%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.31%
H: 0.26%
C: -1.34%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
OCUL | News | $5.86 -22.69% -29.35% 6.1M
|
Health Technology
|
| O: 4.45%
H: 7.65%
C: 2.21%
GRFS | News | $6.53 -0.76% -0.77% 760K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -3.74%
ALDX | News | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: 0.0%
H: 2.36%
C: 0.61%
pharma disease pipeline set eye trial
Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published: 2023-05-08 (Crawled : 15:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.11%
H: 0.72%
C: 0.3%
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 6.91%
H: 1.49%
C: -2.49%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -1.19%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 1.43%
H: 2.11%
C: -1.41%
companies report cancer pancreatic global
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Published: 2023-04-26 (Crawled : 15:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: -2.04%
breast asco cancer kisqali novartis trial
Erasca Announces Publication of Promising Clinical Data Supporting the Therapeutic Potential of Naporafenib in Combination with Trametinib in NRAS-Mutant Melanoma
Published: 2023-04-25 (Crawled : 15:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 5.0%
H: 0.0%
C: -0.57%
ERAS | $1.795 -2.45% -2.51% 650K
|
|
| O: 0.0%
H: 2.59%
C: -3.7%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 4.24%
H: 0.68%
C: -0.77%
melanoma publication potential
Gallbladder Cancer Therapeutics Market size to grow by USD 103.57 million from 2021 to 2026, Driven by the strong incidence of gallbladder cancer in developing countries - Technavio
Published: 2023-04-12 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 3.22%
H: 0.01%
C: 0.01%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 1.92%
H: 0.77%
C: 0.56%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.75%
H: 0.5%
C: -0.05%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
cancer therapeutics market
Motion Sickness Treatment Market to Reach $525 Million, Globally, by 2031 at 2.9% CAGR: Allied Market Research
Published: 2023-03-28 (Crawled : 15:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.42%
H: 1.06%
C: 1.06%
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -0.46%
H: 1.84%
C: 0.81%
PBH | $68.35 0.47% 0.0% 220K
|
Health Technology
|
| O: -0.5%
H: 1.17%
C: 0.84%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.38%
H: 1.25%
C: 1.12%
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
|
| O: -0.45%
H: 0.83%
C: -0.1%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.37%
H: 0.14%
C: -1.01%
treatment research market
Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation
Published: 2023-03-21 (Crawled : 15:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -1.15%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.25%
H: 0.19%
C: 0.04%
hyrimoz fda biosimilar approval
High Adoption Rate Of A New Treatment Against Cancer is likely to proliferate the Neuroendocrine Tumor Treatment CAGR: 10%|UnivDatos Market Insights
Published: 2023-02-03 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: -0.45%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.02%
H: 0.71%
C: -0.27%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.75%
H: 0.6%
C: -0.49%
treatment tumor cancer market
Global Active Pharmaceutical Ingredients (APIs) Market Report, 2022 & 2023-2027: Biotech APIs Used in Biologics are Increasingly Becoming the Top-Selling Drugs in the Market
Published: 2023-01-16 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
| Email alert
Add to watchlist
global active biotech market
Global Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGR
Published: 2023-01-09 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.0%
C: -2.55%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -1.71%
H: 0.42%
C: -3.32%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.76%
H: 0.26%
C: -3.27%
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M
|
Health Technology
|
| O: 0.35%
H: 9.67%
C: 3.25%
SRRK A | $13.96 1.9% 1.86% 860K
|
Health Technology
|
| O: 1.5%
H: 2.42%
C: -0.11%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 0.1%
H: 10.44%
C: 5.66%
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: -0.17%
H: 0.84%
C: -7.91%
treatment global report market muscular atrophy
Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -0.74%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -0.25%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.01%
H: 0.08%
C: -0.95%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.37%
H: 0.89%
C: 0.4%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.46%
H: 0.38%
C: 0.01%
global report sanofi market
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.